Open AccessEffects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus
Author(s) -
Ali I. AlGareeb,
Haidar F Alrubai,
Sammar M Suliaman
Publication year - 2016
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.176355
Subject(s) - gliclazide , medicine , metformin , glycemic , type 2 diabetes mellitus , diabetes mellitus , type 2 diabetes , insulin resistance , insulin , rosiglitazone , adipokine , regimen , endocrinology , gastroenterology
Omentin is a newly identified adipokine that has beneficial influence against cardiovascular disorders. Hence, considering the impact of anti-diabetic drug on omentin levels may provide an adjuvant strategy to protect diabetic patients against valuable clinical hazards.